Clinical study of indocyanine green near infrared fluorescence navigation assisted surgical resection of bone and soft tissue tumors

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047628

Enrollment

Unknown

Registered

2021-06-21

Start date

2021-05-26

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone and soft tissue tumours

Interventions

experimental group:Preoperative ICG injection+Clinical routine R0 resection under fluorescent navigation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis was bone or soft tissue tumors; 2. The expected survival time was more than 3 months; 3. There were no other contraindications to cardiovascular surgery and anesthesia.

Exclusion criteria

Exclusion criteria: 1. Severe chronic kidney, liver or lung diseases; 2. Patients with thyroid autonomous nodules and hypersensitivity to iodine or shellfish; 3. Multiple organ failure; 4. Shock.

Design outcomes

Primary

Measure	Time frame
Does fluorescent navigation have guiding significance for surgery;Positive margin;	—

Secondary

Measure	Time frame
Wound infection (yes or no);Quality of life score: QOL score;Operative time;Tumor recurrence;2-year disease free survival rate;	—

Countries

China

Contacts

Public ContactCai Lin

Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University

orthopedics@whu.edu.cn+86 13886096467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026